
Gliford M 2mg/500mg Tablet ER
Marketer
Crossford Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Gliford M 2mg/500mg Tablet ER
Diabex Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, manifesting as sweating, dizziness, headache, or tremors. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential for prevention. Alcohol consumption should be limited due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Consult your doctor before using Diabex Duo if pregnant or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.
Uses of Gliford M 2mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Gliford M 2mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gliford M 2mg/500mg Extended-Release tablet whole; do not break, crush, or chew it. Administer this medication with food.
Common Side effects of Gliford M 2mg/500mg Tablet ER:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Gliford M 2mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Gliford M 2mg/500mg Extended-Release Tablets. Ingest the tablets whole; do not break, crush, or chew them. Administer with food.
How Gliford M 2mg/500mg Tablet ER works:
Gliford M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Gliford M 2mg/500mg Extended-Release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Gliford M 2mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. Your physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Extended-release Gliford M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Patients with kidney impairment should use Gliford M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gliford M 2mg/500mg Extended-Release tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Gliford M 2mg/500mg Extended-Release tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should typically begin with a low dose; however, its use is contraindicated in those with severe liver disease. Medical advice is recommended.
What if you forget to take Gliford M 2mg/500mg Tablet ER :
Should you forget to take a Gliford M 2mg/500mg Extended-Release tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliford M 2mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
